Report cover image

Neurosigma Inc - Product Pipeline Analysis, 2026 Update

Publisher GlobalData
Published Apr 20, 2026
Length 46 Pages
SKU # GBDT21121834

Description

Summary

Neurosigma Inc (Neurosigma) is a life science company that develops and commercializes trigeminal nerve stimulation technologies for neurologic and psychiatric disorders. The company's products include monarch eTNS system and trigeminal nerve stimulation. Monarch eTNS system is a cleared device is indicated for the treatment of pediatric attention deficit hyperactivity disorder (ADHD) as a monotherapy in patients. The device is used for patient treatment by prescription only and is intended to be used in the home under the supervision of a caregiver during periods of sleep. NeuroSigma is headquartered in Los Angeles, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Neurosigma Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note:Some sections may be missing if data is unavailable for the company

Table of Contents

46 Pages
Neurosigma Inc Company Overview
Neurosigma Inc Company Snapshot
Neurosigma Inc Pipeline Products and Ongoing Clinical Trials Overview
Neurosigma Inc – Pipeline Analysis Overview
Neurosigma Inc - Key Facts
Neurosigma Inc - Major Products and Services
Neurosigma Inc Pipeline Products by Development Stage
Neurosigma Inc Ongoing Clinical Trials by Trial Status
Neurosigma Inc Pipeline Products Overview
Deep Brain Stimulation System - Cachexia
Deep Brain Stimulation System - Cachexia Product Overview
Deep Brain Stimulation System - Obesity
Deep Brain Stimulation System - Obesity Product Overview
DELTA Stent
DELTA Stent Product Overview
Micropatterned TFN Stent
Micropatterned TFN Stent Product Overview
Monarch eTNS System - Autism Spectrum Disorder (ASD)
Monarch eTNS System - Autism Spectrum Disorder (ASD) Product Overview
Monarch eTNS System - Autism Spectrum Disorder (ASD) Clinical Trial
Monarch eTNS System - Depression
Monarch eTNS System - Depression Product Overview
Monarch eTNS System - Epilepsy
Monarch eTNS System - Epilepsy Product Overview
Monarch eTNS System - Lennox-Gastaut Syndrome
Monarch eTNS System - Lennox-Gastaut Syndrome Product Overview
Monarch eTNS System - Post-Traumatic Stress Disorder
Monarch eTNS System - Post-Traumatic Stress Disorder Product Overview
Monarch eTNS System - Traumatic Brain Injury
Monarch eTNS System - Traumatic Brain Injury Product Overview
Next-Generation eTNS System
Next-Generation eTNS System Product Overview
sTNS System - Epilepsy
sTNS System - Epilepsy Product Overview
Thin Film Nitinol Flow Diverting Stent
Thin Film Nitinol Flow Diverting Stent Product Overview
Neurosigma Inc - Key Competitors
Neurosigma Inc - Key Employees
Neurosigma Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Neurosigma Inc, Recent Developments
Dec 15, 2025: NeuroSigma Completes $1 Million Investment into High-Volume Manufacturing Line for Second Generation Monarch eTNS Device
Nov 18, 2025: NeuroSigma Launches Next-Generation Monarch Device for Pediatric ADHD
Nov 18, 2025: NeuroSigma Launches Next-Generation Monarch Device for Pediatric ADHD After Successful Pilot Program
Nov 03, 2025: NeuroSigma Publishes Study on Real-Time Effects of External Trigeminal Nerve Stimulation on Brain Activity
Nov 03, 2025: NeuroSigma Announces New Publication Showing Real-Time Effects of External Trigeminal Nerve Stimulation (eTNS) on Brain Activity
Jun 10, 2025: NeuroSigma Announces Notice of Allowance for Patent Protecting Monarch eTNS System in China
Apr 30, 2025: NeuroSigma Announces New Clinical Trial of Monarch eTNS System for Treatment of ADHD in Children with Fetal Alcohol Syndrome at UCLA
Jan 22, 2025: NeuroSigma Announces Patent Application Protecting Use of Trigeminal Nerve Stimulation to Include Treatment of Dyslexia and Other Neurodevelopmental Disorders
Jan 13, 2025: Clinical Trial of Neurosigma’s Monarch eTNS System for ADHD at King’s College London Completes Enrollment
Dec 11, 2024: New Clinical Trial of eTNS for Pediatric ADHD to Commence at Denmark’s Center for Evidence-Based Psychiatry
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Neurosigma Inc Pipeline Products and Ongoing Clinical Trials Overview
Neurosigma Inc Pipeline Products by Equipment Type
Neurosigma Inc Pipeline Products by Indication
Neurosigma Inc Ongoing Clinical Trials by Trial Status
Neurosigma Inc, Key Facts
Neurosigma Inc, Major Products and Services
Neurosigma Inc Number of Pipeline Products by Development Stage
Neurosigma Inc Pipeline Products Summary by Development Stage
Neurosigma Inc Ongoing Clinical Trials by Trial Status
Neurosigma Inc Ongoing Clinical Trials Summary
Deep Brain Stimulation System - Cachexia - Product Status
Deep Brain Stimulation System - Cachexia - Product Description
Deep Brain Stimulation System - Obesity - Product Status
Deep Brain Stimulation System - Obesity - Product Description
DELTA Stent - Product Status
DELTA Stent - Product Description
Micropatterned TFN Stent - Product Status
Micropatterned TFN Stent - Product Description
Monarch eTNS System - Autism Spectrum Disorder (ASD) - Product Status
Monarch eTNS System - Autism Spectrum Disorder (ASD) - Product Description
Monarch eTNS System - Autism Spectrum Disorder (ASD) - A Study to Evaluate Efficacy of Monarch eTNS System as a Novel Treatment in Pediatric Subjects with Autism Spectrum Disorder (ASD)
Monarch eTNS System - Autism Spectrum Disorder (ASD) - Phase IIa Clinical Trial of External Trigeminal Nerve Stimulation for Autistic Children With Attention Deficit/Hyperactivity Disorder
Monarch eTNS System - Depression - Product Status
Monarch eTNS System - Depression - Product Description
Monarch eTNS System - Epilepsy - Product Status
Monarch eTNS System - Epilepsy - Product Description
Monarch eTNS System - Lennox-Gastaut Syndrome - Product Status
Monarch eTNS System - Lennox-Gastaut Syndrome - Product Description
Monarch eTNS System - Post-Traumatic Stress Disorder - Product Status
Monarch eTNS System - Post-Traumatic Stress Disorder - Product Description
Monarch eTNS System - Traumatic Brain Injury - Product Status
Monarch eTNS System - Traumatic Brain Injury - Product Description
Next-Generation eTNS System - Product Status
Next-Generation eTNS System - Product Description
sTNS System - Epilepsy - Product Status
sTNS System - Epilepsy - Product Description
Thin Film Nitinol Flow Diverting Stent - Product Status
Thin Film Nitinol Flow Diverting Stent - Product Description
Neurosigma Inc, Key Employees
Neurosigma Inc, Subsidiaries
Glossary
List of Figures
Neurosigma Inc Pipeline Products by Equipment Type
Neurosigma Inc Pipeline Products by Development Stage
Neurosigma Inc Ongoing Clinical Trials by Trial Status

Search Inside Report

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us